BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32814955)

  • 1. Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer.
    Chan CW; Parker K; Tesic V; Baldwin A; Tang NY; van Wijk XMR; Yeo KJ
    Am J Clin Pathol; 2020 Oct; 154(5):620-626. PubMed ID: 32814955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer.
    Chan CW; Yi X; Lenza M; Baldwin AD; Jakalski J; Tesic V; Yeo KJ
    Am J Clin Pathol; 2022 Jan; 157(1):109-118. PubMed ID: 34463315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.
    Wolff F; Dahma H; Duterme C; Van den Wijngaert S; Vandenberg O; Cotton F; Montesinos I
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115140. PubMed ID: 32829098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of three fully-automated SARS-CoV-2 antibody assays.
    Hörber S; Soldo J; Relker L; Jürgens S; Guther J; Peter S; Lehmann R; Peter A
    Clin Chem Lab Med; 2020 Aug; 58(12):2113-2120. PubMed ID: 32745068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients.
    Pflüger LS; Bannasch JH; Brehm TT; Pfefferle S; Hoffmann A; Nörz D; van der Meirschen M; Kluge S; Haddad M; Pischke S; Hiller J; Addo MM; Lohse AW; Schulze Zur Wiesch J; Peine S; Aepfelbacher M; Lütgehetmann M
    J Clin Virol; 2020 Sep; 130():104549. PubMed ID: 32763809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral Immune Response to SARS-CoV-2.
    Herroelen PH; Martens GA; De Smet D; Swaerts K; Decavele AS
    Am J Clin Pathol; 2020 Oct; 154(5):610-619. PubMed ID: 32808976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.
    Egger M; Bundschuh C; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
    Clin Chim Acta; 2020 Oct; 509():18-21. PubMed ID: 32485155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Truvian Easy Check COVID-19 IgM/IgG Lateral Flow Device for Rapid Anti-SARS-CoV-2 Antibody Detection.
    Chan CW; Shahul S; Coleman C; Tesic V; Parker K; Yeo KJ
    Am J Clin Pathol; 2021 Feb; 155(2):286-295. PubMed ID: 33135049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation.
    Higgins V; Fabros A; Kulasingam V
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33483360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay.
    Kittel M; Findeisen P; Muth MC; Thiaucourt M; Gerhards C; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Apr; 105():632-638. PubMed ID: 33578017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2.
    Riester E; Majchrzak M; Mühlbacher A; Tinguely C; Findeisen P; Hegel JK; Laimighofer M; Rank CM; Schönfeld K; Langen F; Laengin T; Niederhauser C
    Infect Dis Ther; 2021 Dec; 10(4):2381-2397. PubMed ID: 34368915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fully automated assays for the detection of Rubella IgM and IgG antibodies by the Elecsys(®) immunoassay system.
    van Helden J; Grangeot-Keros L; Vauloup-Fellous C; Vleminckx R; Masset F; Revello MG
    J Virol Methods; 2014 Apr; 199():108-15. PubMed ID: 24487099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data.
    Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E
    PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2.
    Muench P; Jochum S; Wenderoth V; Ofenloch-Haehnle B; Hombach M; Strobl M; Sadlowski H; Sachse C; Torriani G; Eckerle I; Riedel A
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32747400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay.
    Riester E; Findeisen P; Hegel JK; Kabesch M; Ambrosch A; Rank CM; Pessl F; Laengin T; Niederhauser C
    J Virol Methods; 2021 Nov; 297():114271. PubMed ID: 34461153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.